New guidelines, growth opportunities, and investment in new technologies

Our Press & Policy

Stay up to date with the latest IVD sector news and developments in health policy.

07Jan

The British In Vitro Diagnostics Association (BIVDA) calls for vaccinations for industry frontline key workers

07 Jan, 2021 | Return|

BIVDA represents the industry sector who manufacture and distribute diagnostic tests to the NHS. These rely on a high level of automation and so industry has service engineers and technical specialists working in NHS pathology laboratories alongside NHS staff to ensure that the equipment is maintained and allowing diagnostic test results to be issued without delay.  Doris-Ann Williams, BIVDA’s Chief Executive said “This equipment will have been subjected to infected samples and we believe our industry staff  designated as key workers, should be vaccinated in line with the guidance issued from the JCVI Green book chapter on COVID-19.  If these key specialists are infected by COVID there will not be sufficient resource to support the very analysers that perform the testing”.

It is likely there will be key workers in other sectors of the life science industries who also work alongside frontline NHS clinical staff and BIVDA would support vaccination for these individuals as well.  BIVDA has been working closely with Government Ministers throughout this pandemic and is confident that they will support vaccinations for these critical industry personnel. 

ENDS
 

Interested in becoming a member? Join us!

Copyright 2024 BIVDA Ltd is registered in England
Company Number 2687137
Registered Office is 299 Oxford Street (5th floor),
London, W1C 2DZ. VAT Number 563105858